Lagumdzija A, Pernow Y, Bucht E, Gonon A, Petersson M
Department of Molecular Medicine, Endocrine and Diabetes Unit, Karolinska Institutet and Karolinska University Hospital, S-17176 Stockholm, Sweden.
Peptides. 2005 Sep;26(9):1661-6. doi: 10.1016/j.peptides.2005.02.007. Epub 2005 Mar 2.
In the present study, we investigated whether nitric oxide (NO) could be involved in the effects of arg-vasopressin (AVP) on osteoblast-like cells. Cells derived from endothelial nitric oxide synthase (eNOS)-knockout mice and their wild type (WT) counterparts, and an osteosarcoma cell line (SaOS-2) were used. AVP (10-100 pmol/l) increased proliferation of osteoblast-like cells from WT mice. The effect was abolished by an AVP V1-receptor antagonist. AVP increased proliferation of cells from eNOSKO mice only when a NO donor, SNAP, was added. A nitric oxide synthase-inhibitor, L-NAME, antagonized the increase in cell proliferation in response to AVP in SaOS-2 cells. In conclusion, this study indicates that NO is involved in the effects of AVP on cell proliferation in osteoblast-like cells.
在本研究中,我们调查了一氧化氮(NO)是否参与精氨酸加压素(AVP)对成骨样细胞的作用。使用了源自内皮型一氧化氮合酶(eNOS)基因敲除小鼠及其野生型(WT)对照的细胞,以及一种骨肉瘤细胞系(SaOS-2)。AVP(10 - 100 pmol/l)增加了野生型小鼠成骨样细胞的增殖。AVP V1受体拮抗剂消除了该作用。仅当添加NO供体SNAP时,AVP才增加eNOS基因敲除小鼠细胞的增殖。一氧化氮合酶抑制剂L-NAME拮抗了SaOS-2细胞中AVP诱导的细胞增殖增加。总之,本研究表明NO参与了AVP对成骨样细胞增殖的作用。